Compare Public Storage (PSA) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Public Storage vs 10X Genomics Inc — how do they compare? Public Storage trades at $285.55 (market cap $52.69B), while 10X Genomics Inc trades at $79.4 (market cap $9.92B). The key difference: Public Storage is far larger — about 5.3× 10X Genomics Inc's market cap, and Public Storage pays a 4.26% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Public Storage for 130 Days and 10X Genomics Inc for 92 Days on average.
| PSA | TXG | |
|---|---|---|
Market Cap | $52.69B | $9.92B |
Volume | 975,662 | 9,372,166 |
Sector | Real Estate | Health |
52-Week High | $330.47 | $97.74 |
52-Week Low | $258.44 | $11.48 |
Typical Hold Time | 130 Days | 92 Days |
Enterprise Value | $66.96B | $9.44B |
Dividend Yield | 4.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Public Storage (PSA) trades at $285.52, down 0.12% on the day, with a bearish technical signal. The stock shows strong profitability with a 41.8% net income margin and has beaten earnings estimates for three consecutive quarters. Recent corporate actions include the completion of the Public Storage Canada acquisition and a $3.00 dividend declared for payment in October 2026. Analyst consensus is a Buy with a $328.33 price target, implying potential upside.
The outlook is mixed; strong fundamentals and analyst support suggest long-term value, but near-term technical weakness and fluctuating cash flows pose risks. Investors should weigh the high valuation multiples against the company's operational resilience and dividend yield.
10x Genomics (TXG) trades at $77.28, down 4.19% on the day, amid a bearish technical signal. The company reported revenue of $642.82M in 2025, with a net loss of $43.54M, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights the launch of its Atera spatial biology platform and a patent victory, signaling innovation and market strength. Cash flow from operations improved to $136.05M in 2025, indicating better operational efficiency.
The outlook is cautiously optimistic, with strong product demand and improving margins offering upside potential. However, persistent losses, high valuation multiples, and competitive pressures present significant risks. Analyst consensus is mixed, with a $74.30 price target slightly below the current price, reflecting uncertainty about near-term profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
